OTC · Healthcare
FOXO TECHNOLOGIES INC. (FOXO)
As-reported financials and recent SEC filings for FOXO TECHNOLOGIES INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$16.4M
Net income
$-12.4M
Net margin
-75.9%
Diluted EPS
—
ROE
-112.2%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $16.4M | $4.1M | $145,291 | $511,000 | $120,000 |
| Gross profit | — | — | $13,291 | $167,000 | $0 |
| Operating income | $-10.3M | $-7.8M | $-22.2M | $-40.2M | $-15.0M |
| Net income | $-12.4M | $-12.4M | $-26.5M | $-95.3M | $-38.5M |
| Diluted EPS | — | — | — | — | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-07-06
View on EDGAR →8-K2026-07-01
View on EDGAR →DEF 14C2026-06-02
View on EDGAR →8-K2026-05-28
View on EDGAR →8-K2026-05-22
View on EDGAR →PRE 14C2026-05-20
View on EDGAR →8-K2026-05-18
View on EDGAR →10-Q2026-05-15
View on EDGAR →Largest Healthcare peers
Go deeper on FOXO
Search FOXO TECHNOLOGIES INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.